Clinical Trial

Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

Study acronym: IN-HOME BP
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-14; most recent amendment 2026-01-08.
Status change: Not Yet Recruiting → Recruiting 2026-01-08
Trial Details
NCT Number NCT07232017
Lead Sponsor Anita Misra-Hebert
Collaborators: Patient-Centered Outcomes Research Institute, The Cleveland Clinic
Conditions Hypertension (HTN)
Enrollment 1,520 participants
Start Date 2026-01-06
Primary Completion 2029-04 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-09